This trial is testing a gene therapy to treat patients with Alzheimer's who have two copies of the APOE4 gene. The trial will test different doses to see what is effective.
5 Primary · 14 Secondary · Reporting Duration: 1 year
Experimental Treatment
15 Total Participants · 6 Treatment Groups
Primary Treatment: LX1001 · No Placebo Group · Phase 1 & 2
Age 18+ · All Participants · 9 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: